General Information of the Compound
| Compound ID |
CP0572863
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[3-[2-[4-[4-[12-[[2-(1-adamantyl)acetyl]amino]dodecyl]piperazin-1-yl]-2-methoxyanilino]-5-methyl-7-oxopyrido[2,3-d]pyrimidin-8-yl]phenyl]propanamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C52H72N8O4
|
||||||||||||||||||
| Molecular Weight |
873.2
|
||||||||||||||||||
| Canonical SMILES |
CCC(=O)Nc1cccc(c1)-n1c2nc(Nc3ccc(cc3OC)N3CCN(CCCCCCCCCCCCNC(=O)CC45CC6CC(CC(C6)C4)C5)CC3)ncc2c(C)cc1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C52H72N8O4/c1-4-47(61)55-41-16-15-17-43(30-41)60-49(63)26-37(2)44-36-54-51(57-50(44)60)56-45-19-18-42(31-46(45)64-3)59-24-22-58(23-25-59)21-14-12-10-8-6-5-7-9-11-13-20-53-48(62)35-52-32-38-27-39(33-52)29-40(28-38)34-52/h15-19,26,30-31,36,38-40H,4-14,20-25,27-29,32-35H2,1-3H3,(H,53,62)(H,55,61)(H,54,56,57)
Show/Hide
|
||||||||||||||||||
| InChIKey |
GDQXEVQGLSPXRS-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00845, RAC-alpha serine/threonine-protein kinase
Protein ID: PT01131, RAC-beta serine/threonine-protein kinase
Protein ID: PT01022, RAC-gamma serine/threonine-protein kinase